Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: Multicenter prospective randomized trial

Langenbeck's Archives of Surgery

Volumn 386, Issue 8, 2002, Pages 575-581

  Kato, T ^a   Ohashi, Y ^b   Nakazato, H ^c   Koike, A ^d   Saji, S ^e   Suzuki, H ^f   Takagi, H ^g   Nimura, Y ^h   Hasumi, A ⁱ   Baba, S ^j   Manabe, T ^k   Maruta, M ⁱ   Miura, K ⁱ   Yamaguchi, A ^l  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Yokoyama Gastrointestinal Hospital   (Japan)

^d AICHI MEDICAL UNIVERSITY   (Japan)

^e GIFU UNIVERSITY   (Japan)

^f Mie Prefectural General Medical Center   (Japan)

^g JR Tokai General Hospital   (Japan)

^h NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j Matsuda Hospital   (Japan)

^k NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^l OGAKI MUNICIPAL HOSPITAL   (Japan)

more..

Author keywords

Adjuvant chemotherapy; Colorectal cancer; Oral fluoropyrimidines; Randomized clinical trial; UFT

Indexed keywords

FLUOROPYRIMIDINE DERIVATIVE; UFT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; SIDE EFFECT; SURVIVAL RATE;

ADENOCARCINOMA; ADMINISTRATION, ORAL; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL RATE; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 0036207386     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-002-0278-x     Document Type: Article

References (32)

1. Adjuvant chemotherapy of colorectal cancer: Results of prospectively randomized trials
2. Cooperative study of surgical adjuvant chemotherapy for colorectal cancer: Five-year results after surgery
3. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma
4. Prospective controlled study on the usefulness of Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer
5. Postoperative adjuvant chemotherapy with mitomycin C and UFT for curatively resected rectal cancer. Results from the cooperative project no.7 Group of the Japanese Foundation for Multidisciplinary Treatment of Cancer
6. UFT plus oral leucovorin: A new oral treatment for colorectal cancer
7. Uracil-tegafur in gastric carcinoma: A comprehensive review
8. Report on nationwide pooled data and cohort investigation in UFT phase II study
9. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
10. The randomization and stratification of patients to clinical trials
11. Cooperative study of surgical adjuvant chemotherapy for colorectal carcinoma
12. Prospective adjuvant therapy with mitomycin C and carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU Study Group, the first study for colorectal cancer
13. Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer, five-year follow-up: Tokai HCFU Study Group, third study on colorectal cancer
14. Criteria for the evaluation of the clinical effects of solid cancer chemotherapy
15. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification
16. Discreet sequential boundaries for clinical trials
17. Bayesian approaches to randomized trials
18. Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer
19. Adjuvant therapy for patients with colon and rectal cancer
20. Fluorouracil (FU), leucovorin (LV), and levamisole (LEV) adjuvant therapy for colon cancer
21. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results from four national surgical adjuvant breast and bowel project adjuvant studies (C-01, C-02, C-03, and C-04)
22. UFT plus calcium folinate versus 5-FU plus calcium folinate in colon cancer
23. Recent management of metastatic colorectal cancer
24. A new macroscopic classification predicts for patients with liver metastases from colorectal cancer
25. Extensive en bloc resection of regionally recurrent carcinoma of the rectum
26. Indications of prognosis after hepatic resection for colorectal secondaries
27. Recent advances in the treatment of advanced colorectal cancer
28. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
29. Surgical treatment of colorectal liver metastases
30. Repeat liver resection for recurrent colorectal liver metastases